A321550 logo

TiumBio Co., Ltd. Stock Price

KOSDAQ:A321550 Community·₩292.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A321550 Share Price Performance

₩10,070.00
6625.00 (192.31%)
₩10,070.00
6625.00 (192.31%)
Price ₩10,070.00

A321550 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with weak fundamentals.

0 Risks
1 Reward

TiumBio Co., Ltd. Key Details

₩9.3b

Revenue

₩1.4b

Cost of Revenue

₩7.9b

Gross Profit

₩19.6b

Other Expenses

-₩11.7b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-403.38
84.80%
-125.81%
72.2%
View Full Analysis

About A321550

Founded
2016
Employees
68
CEO
Huntaek Kim
WebsiteView website
www.tiumbio.com

TiumBio Co., Ltd., a drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases. The company’s products pipeline includes chemical entity-based drugs and biopharmaceuticals comprising NCE401, NCE403, NCE406, and NBP604. It has a collaboration agreement with Oncodesign Société Anonyme for the research and development of fibrosis drug candidates. The company was founded in 2016 and is based in Seongnam-si, South Korea.

Recent A321550 News & Updates

Is TiumBio (KOSDAQ:321550) Weighed On By Its Debt Load?

Oct 31
Is TiumBio (KOSDAQ:321550) Weighed On By Its Debt Load?

Recent updates

No updates